Chemours stock rises 24.5% after deal to sell acid business

80
Chemours stock rises 24.5% after deal to sell acid business

Chemours' shares were up 24.5% at $33.76 after the company announced its deal to sell its Glycolic acid business to PureTech Scientific for $137 million.

3 D Systems Inc. rose 12 points to $9.40, a decrease from its previous record of 9.4 percent. 3D Systems has confirmed its proposal to combine with Stratasys.

Macy's Inc. rose 8.1% to $14.87. Macy's reported a decrease of 7% year-on-year to $4.98 billion in the first quarter of this year.